The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

THURSDAY, May 29, 2025 (HealthDay News) — Belly flab appears to be a stronger warning sign for psoriasis than fat located ...

Scalp to shins relief with expert tips - Itching to know what’s causing that scratch? Learn how hydration, barrier repair, ...

The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque ...

Central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly ...

Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...

The market is projected to reach approximately USD 5,912.7 million in 2025 and expand to around USD 11,099.0 million by 2035, ...